Kaplan Fox Files Class Action Against Hims & Hers

Kaplan Fox & Kilsheimer LLP has announced the filing of a class action lawsuit against Hims & Hers Health, Inc. (HIMS), a publicly traded company listed on the New York Stock Exchange. The lawsuit, which was initiated on July 29, 2026, is part of a broader legal action involving the Federal Trade Commission (FTC), the People of the State of California through Los Angeles County Counsel, and the Utah Division of Consumer Protection.

According to the lawsuit, Hims & Hers is accused of failing to clearly disclose to consumers that they are charged for prescriptions almost immediately after submitting an intake form, despite being informed that they would have the opportunity to consult with a medical provider to find a treatment that is "right for them." The FTC also alleges that the company has made it difficult for consumers to cancel subscriptions and has misled them about the privacy of their health information. The FTC further claims that Hims & Hers shared consumers' health information with Meta, Snap, and other third parties.

The lawsuit alleges that throughout the period from August 4, 2025, to July 29, 2026, Hims & Hers made materially false and misleading statements, and failed to disclose material adverse facts to investors. Specifically, the company was accused of sharing consumer health information with third-party advertising platforms, charging consumers for prescriptions almost immediately after intake, and facing regulatory scrutiny as a result of these practices. The lawsuit suggests that these actions increased the likelihood of the company incurring fees and penalties.

Following the news of the lawsuit, Hims & Hers stock experienced a significant drop, falling $4.32 per share, or 14.73%, to close at $25.00 per share on July 29, 2026.

Kaplan Fox & Kilsheimer LLP, a nationally recognized law firm with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey, is encouraging Hims & Hers Health, Inc. investors who purchased or otherwise acquired the company's securities during the class period to contact the firm. The deadline for investors to move the court to serve as a lead plaintiff for the purported class is November 2, 2026. Investors are encouraged to contact the firm to learn more about the lead plaintiff process, although they do not need to seek to become a lead plaintiff to share in any possible recovery.

The firm has a history of prosecuting complex litigation, including securities, antitrust, and consumer protection actions. Founded in 1956, Kaplan Fox & Kilsheimer LLP has recovered more than $10 billion for clients and the classes it has represented. The firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in In re Bank of America, the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act.